Impurity Fate Analysis

Impurity Fate Analysis is a systematic methodological framework within impurity control strategy that identifies, tracks, and evaluates the persistence, transformation, or removal of chemical impurities throughout a pharmaceutical manufacturing process to ensure product safety and regulatory compliance.

5

Publications

112

Citations

33

Authors

7

Institutions

Publications per year

2017–2026

2

Authors

33

  1. PM
    Poncho Meisenheimer

    Promega (United States), United States

    1 publications · 31 citations

    1

    h-index

  2. RJ
    Rodney J. Ketner

    University of California, Santa Cruz, United States

    1 publications · 10 citations

    1

    h-index

  3. JS
    Jeremy Sackett

    Bristol-Myers Squibb (United Kingdom), United Kingdom

    1 publications · 10 citations

    1

    h-index

  4. AA
    Alexey A. Makarov

    Merck & Co., Inc., Rahway, NJ, USA (United States), United States

    1 publications · 35 citations

    1

    h-index

  5. DS
    Daniel S. Hsieh

    Bristol-Myers Squibb (United States), United States

    1 publications · 10 citations

    1

    h-index

1–5 of 33

Venues

  1. Journal of Chromatography B

    1 publications · 35 citations

    1

    h-index

  2. Pharmaceutical Research

    1 publications · 10 citations

    1

    h-index

  3. Journal of Agricultural and Food Chemistry

    1 publications · 14 citations

    1

    h-index

  4. 1

    h-index

  5. Synthesis

    1 publications · 31 citations

    1

    h-index

1–5